Aroa Biosurgery (ASX:ARX) printed NZ$12.6m EBITDA in FY26 then guided FY27 lower as it reinvests NZ$9m into Myriad and Symphony.
Small Caps Stocks
New Zealand King Salmon (ASX:NZK) swung to a A$13.8m 1HY26 profit, upgraded FY26 guidance and lifted FY28 harvest volume targets.
Haranga Resources (ASX:HAR) delivered a maiden JORC of 402koz at 5.1g/t at Lincoln, with existing decline and 315ktpa mill backing the restart case.
Infragreen Group (ASX:IFN) lifts FY26 underlying NPAT 277% and guides to $26m to $28m EBITDA for FY27 ahead of a Grant Samuel review update.
Adore Beauty (ASX:ABY) has guided FY27 EBITDA to $9-13m. After a torrid half decade post IPO, is the company finally delivering for investors?
Service Stream (ASX:SSM) will acquire Queensland-based RIE Group for up to A$8m, adding high-voltage industrial services capability tied to the energy transition.
Raptor Metals (ASX:RAP) drilling at Chester returned 25m at 2.06% CuEq with zinc, lead and silver credits historical drilling never captured.
IMEXHS (ASX:IME) wins a Zacatecas public tender for 20 hospitals, adding A$384k ARR and a showcase site for its agentic radiology AI stack.
Delorean Corporation (ASX:DEL) hits 75% completion at SA1 Salisbury, with first biomethane injection into the Adelaide gas network targeted for November 2026.
Alcidion (ASX:ALC) has signed its A$35m UHSussex EPR contract with A$8.5m recognised in FY26 via an upfront licence fee.
